Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-105438
Filing Date
2024-10-02
Accepted
2024-10-02 16:09:19
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2425390-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2425390-1_4seq1.xml 4 4226
  Complete submission text file 0001104659-24-105438.txt   5697
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Issuer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 400 CAMBRIDGE MA 02140
Business Address
Jorgensen Nathan D. (Reporting) CIK: 0001842523 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37625 | Film No.: 241347377